Abstract
Aim: Presenting the first clinical case of Wickerhamomyces myanmarensis. Patients & methods: Yeast cells were isolated from blood and central venous catheter of a 5.5-year-old male subject. API 20C AUX, MALDI-TOF MS, ITS and LSU rDNA sequencing, and our qPCR assay were used for identification and the MIC values were determined by CLSI M27-A3. Results: ITS and LSU rDNA sequencing identified both isolates as W. myanmarensis, while API 20C AUX and MALDI-TOF MS did not identify them correctly. Our qPCR specifically distinguished W. myanmarensis from W. anomalus. Isolate obtained from blood showed a higher MIC value for fluconazole, voriconazole and posaconazole. Conclusion: Utilization of reliable identification tools might reveal the genuine spectrum of opportunistic yeast species.
| Original language | English |
|---|---|
| Pages (from-to) | 267-274 |
| Number of pages | 8 |
| Journal | Future microbiology |
| Volume | 14 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Mar 2019 |
| Externally published | Yes |
Keywords
- antifungal susceptibility testing
- blood
- central venous catheter
- specific multiplex qPCR
- Wickerhamomyces myanmarensis
Fingerprint
Dive into the research topics of 'First fungemia case due to environmental yeast Wickerhamomyces myanmarensis: Detection by multiplex qPCR and antifungal susceptibility'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver